Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection

Gurakan, F; Kocak, N; Ozen, HASAN; Yuce, A

doi:10.1097/00006454-200001000-00011

Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection

Atıf İçin Kopyala

Gurakan F., Kocak N., Ozen H., Yuce A.

PEDIATRIC INFECTIOUS DISEASE JOURNAL, cilt.19, sa.1, ss.52-56, 2000 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 1
Basım Tarihi: 2000
Doi Numarası: 10.1097/00006454-200001000-00011
Dergi Adı: PEDIATRIC INFECTIOUS DISEASE JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.52-56
Hacettepe Üniversitesi Adresli: Evet

Özet

Background. Interferon is currently the most useful therapeutic agent for chronic viral hepatitis. The aim of this study was to compare the efficacy of standard and high dosages of interferon in children with chronic hepatitis B virus (HBV) infection.